Dr. Agarwals Health Care Ltd.
ShareAGARWALEYE Competitor Analysis
| AGARWALEYE | MAXHEALTH  | APOLLOHOSP | FORTIS | NH | |
|---|---|---|---|---|---|
Overview | |||||
| Current price (₹) As on 30 Sept, 2025, 03:43 PM | 507.35 1.72% | 1,114.70 0.24% | 7,409.00 -0.47% | 969.80 -0.1% | 1,737.60 -1.99% |
| Market cap (₹ Cr) | 16,040 | 1,08,365 | 1,06,530 | 73,216 | 35,510 |
Report Card | |||||
| Quality | |||||
| Growth | |||||
| Momentum | |||||
| Value | |||||
Past ReturnsAbsolute Returns Shown | |||||
| 1D | 2.04% | -1.01% | -0.88% | 4.07% | 2.77% |
| 1W | 8.31% | -3.89% | -3.12% | 0.32% | 2.28% |
| 1M | 15.33% | -3.66% | -2.18% | 6.5% | 1.08% |
| 3M | 23.21% | -12.85% | 2.79% | 22.18% | -18.32% |
| 6M | 11.86% | 1.37% | 12.51% | 39.01% | 4.77% |
| 1Y | -- | 12.81% | 3.4% | 57.82% | 41.7% |
| 5Y | -- | 864.02% | 246.55% | 617.48% | 395.2% |
Income StatementAnnual data as on 30 Sept 2025. All values in ₹ Cr. YoY growth displayed | |||||
| Sales | 1,711 28.45% | 7,028 30% | 21,794 14.35% | 7,783 12.91% | 5,483 9.27% |
| OPM (%) | 25.97 -1.33% | 25.73 -3.71% | 13.74 10.18% | 20.23 10.61% | 22.89 1.19% |
| PBT | 159.85 13.72% | 1,406 3% | 2,006 47.18% | 995.52 17.33% | 935.54 5.29% |
PAT | 110.34 16.09% | 1,076 1.7% | 1,472 60.52% | 797.86 25.51% | 790.63 0.13% |
| Net Profit Margin | 6.45 -9.66% | 15.31 -21.73% | 6.91 40.73% | 10.4 11.11% | 14.42 -8.39% |
| EPS | 2.64 -97.03% | 11.07 1.75% | 100.56 60.92% | 10.26 29.38% | 38.66 0.1% |
Balance Sheet & Cash FlowAnnual data as on 30 Sept 2025. All values in ₹ Cr. YoY growth displayed | |||||
| Net Worth | 1,867 39.43% | 9,381 12.47% | 8,212 18.41% | 8,917 16.39% | 3,624 25.66% |
| Total Assets | 3,672 33.38% | 15,214 26.78% | 20,657 23.3% | 13,692 3.03% | 7,265 29.16% |
| Total Outside Liabilities | 1,805 27.74% | 5,834 59.44% | 12,445 26.76% | 4,775 -15.16% | 3,641 32.83% |
| Cash from Operating Activity | 360.33 4.15% | 1,459 30.04% | 2,136 11.25% | 1,424 29.45% | 985.78 -7.61% |
| Cash from Investment Activity | -750.33 17.89% | -1,632 -27% | -3,381 -119.97% | -779.38 12.07% | -1,325 9.12% |
| Cash from Financing Activity | 381.85 -30.91% | -163.8 37.89% | 1,317 523.2% | -713.85 -725.64% | 544.31 11.44% |
| Net Cash Flow | -8.15 46.49% | -318.6 19.24% | 72.6 0.83% | -69.76 -156.02% | 205.42 111.45% |
RatiosAnnual data as on 30 Sept 2025. | |||||
| PB | 7.56 | 11.37 | 11.60 | 5.91 | 9.54 |
| PE | 192.19 | 100.72 | 73.68 | 94.57 | 44.94 |
| ROE (%) | 6.88 | 12.14 | 19.44 | 9.63 | 24.30 |
| Dividend Yield (%) | 0 | 0.13 | 0.26 | 0.10 | 0.26 |
| ROCE (%) | 14.15 | 15.40 | 20.90 | 12.93 | 21.45 |
